IQVIA HOLDINGS INC
IQV · NYSE
Updated at 2026-10-14 08:10:33
- Today's High
- $265.00
- Today’s Low
- $259.61
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $260.23
- Previous Close
- $262.21
- Volume
- 1.08M
- Market Cap
- $43.15B
- P/E Ratio
- 31.34X
- EPS
- $8.06
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- DIAGNOSTICS & RESEARCH
- Headquarters
- 2400 ELLIS ROAD, DURHAM, NC, UNITED STATES, 27703
- Country
- US
- Listing Date
- 2013-05-09
- Fiscal Year End
- December
- Shares Outstanding
- 164.6M
- CIK
- 0001478242
- Website
- ir.iqvia.com
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Financial Metrics
Revenue
2026-06-30
$4.36B
2026-03-31
$4.15B
2025-12-31
$4.36B
2025-09-30
$4.1B
Operating Expenses
2026-06-30
$929M
2026-03-31
$841M
2025-12-31
-$440M
2025-09-30
$820M
Net Income
2026-06-30
$256M
2026-03-31
$274M
2025-12-31
$514M
2025-09-30
$331M
Net Profit Margin
2026-06-30
5.86%
2026-03-31
6.6%
2025-12-31
11.77%
2025-09-30
8.07%
Earnings Per Share
2026-06-30
$2.75
2026-03-31
$2.90
2025-12-31
$3.42
2025-09-30
$3.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$790M
2026-03-31
$808M
2025-12-31
$1.04B
2025-09-30
$883M
Effective Tax Rate
2026-06-30
19.93%
2026-03-31
17.98%
2025-12-31
10.13%
2025-09-30
18.62%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $4.36B | $4.15B | $4.36B | $4.1B |
| Operating Expenses | $929M | $841M | -$440M | $820M |
| Net Income | $256M | $274M | $514M | $331M |
| Net Profit Margin | 5.86% | 6.6% | 11.77% | 8.07% |
| Earnings Per Share | $2.75 | $2.90 | $3.42 | $3.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $790M | $808M | $1.04B | $883M |
| Effective Tax Rate | 19.93% | 17.98% | 10.13% | 18.62% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.